A single nucleotide polymorphism in the MTOR gene is associated with recurrent spontaneous abortion in the Chinese

Huifen Xiang1, Shengnan Liu, Chen Zong

  • 1Reproductive Medicine Center .

Insights

A specific gene variant (rs17027478) in the mammalian target of rapamycin (MTOR) gene is linked to recurrent spontaneous abortion (RSA) risk in women with multiple miscarriages. This MTOR gene variant may contribute to RSA development.

Area of Science:

  • Genetics and Reproductive Medicine
  • Molecular Biology and Disease Pathogenesis

Background:

  • Recurrent spontaneous abortion (RSA) is a complex condition with multifactorial causes.
  • The mammalian target of rapamycin (MTOR) gene plays a crucial role in embryonic development and stem cell regulation.

Purpose of the Study:

  • To investigate the association between the single nucleotide polymorphism (SNP) rs17027478 in the MTOR gene promoter and the risk of recurrent spontaneous abortion (RSA).
  • To explore the functional impact of the rs17027478 variant on MTOR gene expression and its potential role in RSA pathogenesis.

Main Methods:

  • A case-control study involving 306 RSA patients and 127 healthy controls.
  • Genotyping of the MTOR rs17027478 SNP using TaqMan assay.
  • Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and luciferase reporter assays to assess gene function.

Main Results:

  • A significant association was found between the MTOR rs17027478 variant and increased RSA risk in women with three or more miscarriages (p=0.043).
  • Lower MTOR mRNA levels were observed in RSA patients compared to healthy controls (p=0.020).
  • The rs17027478A allele significantly reduced luciferase activity, indicating a functional impact on gene expression (p=0.029).

Conclusions:

  • The MTOR gene variant rs17027478 in the promoter region is a potential candidate contributing to the pathogenesis of recurrent spontaneous abortion.
  • This genetic variation may influence MTOR gene expression, impacting embryonic development and contributing to pregnancy loss.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K